Medicare Enrolled
Dr. Nima Amjadi, M.D.
Interventional Cardiology · Dripping Springs, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amjadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amjadi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amjadi
Dr. Nima Amjadi is an interventional cardiology in Dripping Springs, TX, with 19 years in practice. Based on federal Medicare data, Dr. Amjadi performed 4,578 Medicare services across 3,056 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amjadi received a total of $29,977 from 68 pharmaceutical and/or device companies across 1168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amjadi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 16% volume in TX$ $29,977 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,578
Medicare services
Top 16% in TX for interventional cardiology
3,056
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~241 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,080 | $89 | $395 |
| Electrocardiogram (EKG), 12-lead | 685 | $10 | $45 |
| Remote patient monitoring device, 30 days | 278 | $42 | $260 |
| Echocardiogram, transthoracic | 258 | $139 | $650 |
| Remote patient monitoring management, 20 min/month | 228 | $40 | $110 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 203 | $16 | $260 |
| New patient office visit (45-59 min) | 145 | $122 | $510 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 139 | $31 | $107 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 133 | $21 | $97 |
| Hospital follow-up visit, high complexity | 127 | $94 | $310 |
| Regadenoson injection (Lexiscan) for heart stress test | 124 | $41 | $250 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 110 | $32 | $220 |
| Office visit, established patient, complex (40-54 min) | 105 | $135 | $555 |
| Office visit, established patient (20-29 min) | 90 | $67 | $280 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 70 | $10 | $165 |
| Hospital follow-up visit, moderate complexity | 63 | $61 | $215 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 59 | $151 | $753 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 54 | $10 | $50 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 54 | $19 | $75 |
| Remote pacemaker monitoring, 90 days | 49 | $21 | $90 |
| Remote pacemaker/defibrillator monitoring, 90 days | 49 | $16 | $80 |
| Ultrasound of both sides of head and neck blood flow | 47 | $134 | $640 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 39 | $345 | $1,340 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $50 | $220 |
| Cardiac catheterization | 38 | $178 | $845 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 38 | $124 | $510 |
| Initial hospital admission, high complexity | 37 | $136 | $595 |
| Sleep study including heart rate, breathing, and sleep time | 36 | $118 | $490 |
| Programming of multiple lead pacemaker system | 34 | $62 | $265 |
| Heart rhythm recording of continous external ekg over 8-15 days | 31 | $10 | $50 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 30 | $20 | $80 |
| New patient office visit (30-44 min) | 16 | $82 | $345 |
| Heart muscle strain imaging | 15 | $31 | $130 |
| New patient office visit, complex (60-74 min) | 15 | $159 | $675 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $289 | $4,215 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $73 | $275 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $85 | $320 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $14 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $2 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.9% high complexity
7.6% medium
82.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,977
Total received (2018-2024)
Avg $4,282/year across 7 years
Top 16% in TX for interventional cardiology
68
Companies
1,168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,970 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,008 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,828
2023$3,250
2022$3,057
2021$4,439
2020$4,774
2019$6,728
2018$4,900
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bard Peripheral Vascular, Inc.
$3,823
ABIOMED
$2,838
Janssen Pharmaceuticals, Inc
$2,607
BARD PERIPHERAL VASCULAR, INC.
$2,008
Amgen Inc.
$1,842
Novartis Pharmaceuticals Corporation
$1,539
Boston Scientific Corporation
$1,009
EKOS Corporation
$1,000
AstraZeneca Pharmaceuticals LP
$975
E.R. Squibb & Sons, L.L.C.
$850
SANOFI-AVENTIS U.S. LLC
$726
Medtronic, Inc.
$714
Abbott Laboratories
$677
PFIZER INC.
$639
Regeneron Healthcare Solutions, Inc.
$614
Inari Medical, Inc.
$610
Amarin Pharma Inc.
$593
Penumbra, Inc.
$535
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$514
ShockWave Medical, Inc
$490
Novo Nordisk Inc
$451
iRhythm Technologies, Inc.
$391
Philips North America LLC
$382
Terumo Medical Corporation
$368
Bolton Medical Inc
$344
Medtronic Vascular, Inc.
$313
Impulse Dynamics (USA) Inc.
$261
CORDIS US CORP.
$215
Esperion Therapeutics, Inc.
$209
Philips Electronics North America Corporation
$191
CARDIVA MEDICAL, INC.
$161
Itamar Medical Inc
$161
Arbor Pharmaceuticals, Inc.
$142
Becton, Dickinson and Company
$135
ARBOR PHARMACEUTICALS, INC.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
Shockwave Medical, Inc
$107
Merck Sharp & Dohme LLC
$107
Lexicon Pharmaceuticals, Inc.
$91
Actelion Pharmaceuticals US, Inc.
$85
Inspire Medical Systems, Inc.
$64
LeMaitre Vascular, Inc.
$61
Tactile Systems Technology Inc
$61
Sientra, Inc.
$58
Teleflex LLC
$55
BOSTON SCIENTIFIC CORPORATION
$47
Acist Medical Systems, Inc.
$46
Siemens Medical Solutions USA, Inc.
$46
Baxter Healthcare
$45
CVRx, Inc.
$44
AtriCure, Inc.
$43
Bardy Diagnostics, Inc.
$41
Edwards Lifesciences Corporation
$37
Biosense Webster, Inc.
$36
Lundbeck LLC
$36
Akcea Therapeutics, Inc.
$33
GE HealthCare
$30
MEDICOMP INC
$30
SCPHARMACEUTICALS INC.
$29
Kiniksa Pharmaceuticals International, plc
$29
Gilead Sciences, Inc.
$27
ATRICURE, INC.
$25
Kowa Pharmaceuticals America, Inc.
$22
Cardinal Health 200, LLC
$18
CHIESI USA, INC.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
Astellas Pharma US Inc
$16
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 30.9% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (4067) Tack Endovascular Systems BTK · (6575) Coronary Undivided · (9281) Turbo Elite · (BH4) IGT Devices Undivided · (DD1) Duo Hybrid · ACCESS · ACUSON Sequoia Diagnostic Ultrasound System · AMBULATORY CARDIAC MONITOR · AMPLATZER Occluders · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE ATRICLIP LAA EXCLUSION · AZURE XT DR MRI SURESCAN · AngioSeal · Arcalyst · Artis icono floor · Assurity Pacemaker · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · COBALT DR MRI SURESCAN · CROSSER · CT THROMBECTOMY SYSTEM KIT · CVI Systems · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · CoreValve Evolut · Corlanor · EKOSONIC · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL VASCULAR INTERVENTION · GENERAL - VASCULAR INTERVENTION · GLIDESHEATH SLENDER · GLIDEWIRE · GlideWire · Glidesheath · Grafts · HAWKONE · HYPERLIPIDEMIA - DISEASE · Hillrom - Carnation Ambulatory Monitor · INSPIRE · INVOKANA · Impella · Indigo System · JARDIANCE · JOT DX · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LIFESTREAM · LUTONIX · LUX DX · Legacy · LifeVest · Livalo · MANTA Vascular Closure Device · METACROSS OTW · MULTAQ · MYNX CONTROL · Manta · Merlin Connectivity and Remote · MetaCross · Misago · MynxGrip Vascular Closure Device · NA · NEXLETOL · NORTHERA · OPTIMIZER · OPTOWIRE · OUTBACK · Optimizer · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Perclose ProGlide suture mediated closure system · RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM · ROTABLATOR · RXi Systems · RYBELSUS · Repatha · Reveal LINQ · Rotarex · Rybelsus · S · SAMSCA · SAMURAI · SHINOBI · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEGSEDI · Turnpike LP Catheter · ULTRAVERSE · UPTRAVI · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · Vascular Lithotripsy · WALLSTENT · WATCHMAN · WatchPAT · WatchPATONE · XARELTO · XENOSURE · Xience Sierra Coronary Stent · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $655 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
17
Per 100K population
6.6
County median income
$85,827
Nearest hospital
ASCENSION SETON SOUTHWEST
11.2 mi
11.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Amjadi is a remote & electrophysiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (low-engagement, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Amjadi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amjadi performed 1,080 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amjadi receive payments from pharmaceutical companies?
Yes. Dr. Amjadi received a total of $29,977 from 68 companies across 1,168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amjadi's costs compare to other interventional cardiologys in Dripping Springs?
Dr. Amjadi's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amjadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Dripping Springs
Browse interventional cardiologys in Dripping Springs ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc..
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology